LAMR vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

LAMR

55.7
AI Score
VS
XRAY Wins

XRAY

57.2
AI Score

Investment Advisor Scores

LAMR

56score
Recommendation
HOLD

XRAY

57score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LAMR XRAY Winner
Revenue 1.20B 1.78B XRAY
Net Income 209.54M 27.00M LAMR
Net Margin 17.5% 1.5% LAMR
Operating Income 329.94M 47.00M LAMR
ROE 19.1% 2.0% LAMR
ROA 5.1% 0.5% LAMR
Total Assets 4.12B 5.20B XRAY
Cash 10.61M 239.00M XRAY
Debt/Equity 2.32 1.48 XRAY
Current Ratio 1.43 1.63 XRAY

Relative Price Performance (Last 90 Days)

LAMR 1M: -4.4% · 3M: -1.2% XRAY 1M: -14.2% · 3M: +10.0%

Current Technical Phase

LAMR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 38.1 · Price: $150.77

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.2 · Price: $10.92

Fundamentals Snapshot

Metric LAMR XRAY
Market Cap
Forward P/E 23.3 7.2
Trailing P/E 28.1
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.7% 0.5%
Operating Margin 0.3% 0.1%
EPS 5.38 -2.71
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.